comparemela.com

Latest Breaking News On - Dana cormack - Page 1 : comparemela.com

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO to Participate in Upcoming Investor Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Las vegasChris brinzeyDana cormackBofa securities health care conferenceGenes genetic medicines forumCorporate communicationsSecurities health care conferenceGenes genetic medicines

REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights

ROCKVILLE, Md., May 1, 2024 /PRNewswire/ REGENXBIO Inc. today announced that it will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to discuss its financial results for the.

Chris brinzeyDana cormackCorporate communications

REGENXBIO to Participate in Chardan s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

REGENXBIO to Participate in Chardan s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chris brinzeyDana cormackCorporate communicationsAnnual genetic medicinesCell therapy manufacturing summitGene therapyEvery stage

REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health.

United statesDana cormackJeffreys heierChris brinzeyExchange commissionDrug administrationEuropean medicines agencyRetina research at ophthalmic consultants of bostonClearside biomedical incCorporate communicationsVitreoretinal serviceSecurities exchangeChief executive officerRetina researchOphthalmic consultantsClearside biomedical

REGENXBIO to Participate in Cantor Fitzgerald s Virtual DMD and Other Dystrophy Days

/PRNewswire/ REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in Cantor Fitzgerald s Virtual DMD and Other Dystrophy Days on Wednesday,.

Dana cormackCorporate communicationsCantor fitzgerald

vimarsana © 2020. All Rights Reserved.